Saratoga Health & Biotechnology Portfolio Fund Class Institutional (SBHIX)
| Fund Assets | 10.84M |
| Expense Ratio | 2.60% |
| Min. Investment | $250 |
| Turnover | 22.00% |
| Dividend (ttm) | 0.78 |
| Dividend Yield | 3.07% |
| Dividend Growth | 207.34% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 9, 2025 |
| Previous Close | 25.33 |
| YTD Return | -1.97% |
| 1-Year Return | 13.02% |
| 5-Year Return | 26.72% |
| 52-Week Low | 21.92 |
| 52-Week High | 27.50 |
| Beta (5Y) | 0.58 |
| Holdings | 30 |
| Inception Date | Jan 27, 2003 |
About SBHIX
Saratoga Health & Biotechnology Portfolio Fund Class I is a mutual fund focused on the healthcare and biotechnology sectors. Its primary objective is to achieve long-term capital growth by investing at least 80% of its assets in equity securities of U.S. and foreign companies that are actively engaged in health care, health products, pharmaceuticals, and biotechnology industries. The fund’s portfolio typically includes a diverse selection of companies ranging from pharmaceutical developers to providers of medical technologies and health services. Notable features include a relatively concentrated portfolio, with around 45% of assets allocated to its top ten holdings, reflecting an emphasis on select high-impact companies in the sector. The fund is intended for investors seeking exposure to the dynamic healthcare and biotech markets, and it has an institutional share class with a minimum investment of $250. Although the fund has historically provided competitive long-term returns, it carries a higher expense ratio compared to peers, reflecting the active management involved in sector-specific research and selection. Saratoga Health & Biotechnology Portfolio Fund Class I plays a specialized role in the financial market, catering to those interested in the growth potential and innovation within the health and biotechnology fields.
Performance
SBHIX had a total return of 13.02% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.22%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FIKCX | Fidelity | Fidelity Advisor Health Care Fund - Class Z | 0.59% |
| FSPHX | Fidelity | Fidelity Select Health Care Portfolio | 0.62% |
| FIJYX | Fidelity | Fidelity Advisor Biotechnology Fund - Class Z | 0.61% |
| FACDX | Fidelity | Fidelity Advisor Health Care Fund - Class A | 0.98% |
| FSHCX | Fidelity | Fidelity Select Health Care Services Portfolio | 0.67% |
Top 10 Holdings
51.14% of assets| Name | Symbol | Weight |
|---|---|---|
| Cardinal Health, Inc. | CAH | 6.77% |
| McKesson Corporation | MCK | 5.88% |
| Amgen Inc. | AMGN | 5.86% |
| Cencora, Inc. | COR | 5.40% |
| Jazz Pharmaceuticals plc | JAZZ | 5.31% |
| United Therapeutics Corporation | UTHR | 5.04% |
| Novartis AG ADR | NVSN.MX | 4.56% |
| Regeneron Pharmaceuticals, Inc. | REGN | 4.51% |
| Gilead Sciences, Inc. | GILD | 3.94% |
| Johnson & Johnson | JNJ | 3.89% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 9, 2025 | $0.7788 | Dec 10, 2025 |
| Dec 10, 2024 | $0.2534 | Dec 11, 2024 |
| Dec 8, 2023 | $1.0202 | Dec 11, 2023 |
| Dec 9, 2022 | $1.2749 | Dec 12, 2022 |
| Dec 10, 2021 | $0.7883 | Dec 13, 2021 |
| Dec 11, 2020 | $2.5794 | Dec 11, 2020 |